Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
@article{Ross2009GeneticVI, title={Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy}, author={C. Ross and Hagit Katzov-Eckert and M. Dub{\'e} and B. Brooks and S. Rassekh and A. Barhdadi and Yassamin Feroz-Zada and H. Visscher and A. Brown and M. Rieder and P. Rogers and M. Phillips and B. Carleton and M. Hayden}, journal={Nature Genetics}, year={2009}, volume={41}, pages={1345-1349} }
Cisplatin is a widely used and effective chemotherapeutic agent, although its use is restricted by the high incidence of irreversible ototoxicity associated with it. In children, cisplatin ototoxicity is a serious and pervasive problem, affecting more than 60% of those receiving cisplatin and compromising language and cognitive development. Candidate gene studies have previously reported associations of cisplatin ototoxicity with genetic variants in the genes encoding glutathione S-transferases… CONTINUE READING
Figures and Topics from this paper
Figures
109 Citations
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
- Medicine
- European journal of cancer
- 2020
- 1
Influence of Genetic Variants in TPMT and COMT Associated with Cisplatin Induced Hearing Loss in Patients with Cancer: Two New Cohorts and a Meta-Analysis Reveal Significant Heterogeneity between Cohorts
- Medicine
- PloS one
- 2014
- 42
- PDF
Genetic variation in Otos is associated with cisplatin-induced ototoxicity.
- Medicine
- Pharmacogenomics
- 2014
- 17
Economic impact of a genetic test for cisplatin-induced ototoxicity
- Medicine, Biology
- The Pharmacogenomics Journal
- 2012
- 20
- PDF
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity
- Medicine
- Pharmacogenetics and genomics
- 2017
- 28
Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients
- Medicine
- Genes
- 2020
- PDF
Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF)
- Medicine
- Front. Endocrin.
- 2012
- 12
- Highly Influenced
- PDF
Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients.
- Medicine
- International journal of pediatric otorhinolaryngology
- 2016
- 19
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities
- Medicine
- Clinical Cancer Research
- 2018
- 16
- PDF
References
SHOWING 1-10 OF 41 REFERENCES
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
- Biology, Medicine
- The Pharmacogenomics Journal
- 2008
- 102
- PDF
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.
- Medicine
- European journal of cancer
- 2004
- 274
Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2005
- 360
- PDF
Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2007
- 183
Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
- Medicine
- Anti-cancer drugs
- 2000
- 127
Ototoxicity From Cisplatin Therapy in Childhood Cancer
- Medicine
- Journal of pediatric hematology/oncology
- 2007
- 113
Genotypic Approaches to Therapy in Children
- Medicine
- Annals of the New York Academy of Sciences
- 2007
- 28
- PDF
Risk factors for ototoxicity due to cisplatin.
- Medicine
- Archives of otolaryngology--head & neck surgery
- 1994
- 86
Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer
- Medicine
- Anti-cancer drugs
- 2006
- 46
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.
- Medicine, Biology
- Journal of the National Cancer Institute
- 1999
- 642
- PDF